Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-1079
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-09-14T06:54:58.792174Z
status: published
lens: g_space
sector: health
headline: Artificial Intelligence as an Assistive Tool in Breast Cancer Screening and Diagnosis in the Digital Era
dek: Objective Breast cancer (BC) is a worldwide health task, and its increasing frequency and the associated burden on healthcare professionals are also increasing. Hence, integrating machine learning (ML) and artificial intelligence (AI) into screening and diagnosis is irrefutable in the digital age. A comprehensive systematic review was conducted aimed at assessing the application of AI and ML techniques to enhance BC screening, diagnosis, classification, and tumor marker scoring. Methods An electronic literature…
gain_title: Systematic review finds AI and deep learning models achieve high accuracy on cytology and histopathology images and offer gains in consistency, speed, cost-effectiveness, and reduced pathologist workload in breast cancer screening and diagnosis.
problem_title: (none)
trace_subject: (none)
gain_reading: Systematic review finds AI and deep learning models achieve high accuracy on cytology and histopathology images and offer gains in consistency, speed, cost-effectiveness, and reduced pathologist workload in breast cancer screening and diagnosis.
gain_evidence: have demonstrated high accuracy in analyzing medical images from various modalities, including cytology and histopathology | showing promising outcomes for consistency, rapidity, and cost-effectiveness
problem_reading: (none)
problem_evidence: (none)
quick_read: A systematic review published September 12, 2026 reviewed AI and machine learning techniques for breast cancer screening, diagnosis, classification and tumor marker scoring. It examined advanced deep learning models including ANNs, SVMs, CNNs and faster R-CNN applied to cytology, histopathology and combined imaging-pathology data.

The findings matter because breast cancer incidence and burden on healthcare professionals are increasing, and the review points to measurable gains in accuracy, consistency and rapidity that could ease pathology workloads. What remains uncertain from this abstract is real-world performance across diverse populations, regulatory adoption details, and long-term patient outcomes.
limitation: 
tag: Evidence-backed gain
key_points: Systematic review searched PubMed and Google Scholar for AI, cytology, histology, tumor marker expression, deep learning and machine learning in breast carcinoma pathology. | Reviewed models include artificial neural networks, support vector machines, convolutional neural networks, and faster R-CNN applied to cytology and histopathology images. | Article notes FDA and internationally approved AI software products for breast cancer detection as evidence of translation potential.
rundown: The review was conducted via electronic literature search in PubMed and Google Scholar following systematic review guidelines, including only articles pertaining to breast cancer pathology. It focused on keywords covering AI, cytology, histology, tumor marker expression, deep learning and machine learning.

Results describe AI applications extending to combined imaging-pathology diagnostics and tumor biomarkers, with mention of various Food and Drug Administration and internationally approved AI software products for breast cancer detection illustrating translation potential.
sources:
- peer_reviewed | International Journal of Breast Cancer | https://doi.org/10.1155/ijbc/5575969 | 2026-09-12
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

d6a26ba6f25175a1628e1cc3a086fbb3f99f3280e6bee62117150ef90fad190b

previous

0000000000000000000000000000000000000000000000000000000000000000